Published in J Cell Biol on November 01, 1982
A molecular description of nerve terminal function. Annu Rev Biochem (1983) 1.82
Lysosomes are associated with microtubules and not with intermediate filaments in cultured fibroblasts. Proc Natl Acad Sci U S A (1984) 1.56
Microtubule-associated protein 2 within axons of spinal motor neurons: associations with microtubules and neurofilaments in normal and beta,beta'-iminodipropionitrile-treated axons. J Cell Biol (1985) 1.09
Properties of highly viscous gels formed by neurofilaments in vitro. A possible consequence of a specific inter-filament cross-bridging. Biochem J (1987) 1.06
Identification of a MAP 2-like ATP-binding protein associated with axoplasmic vesicles that translocate on isolated microtubules. J Cell Biol (1986) 1.03
Proteins transported in slow components a and b of axonal transport are distributed differently in the transverse plane of the axon. J Cell Biol (1985) 0.88
Luminal material in microtubules of frog olfactory axons: structure and distribution. J Cell Biol (1984) 0.82
A Stochastic Multiscale Model That Explains the Segregation of Axonal Microtubules and Neurofilaments in Neurological Diseases. PLoS Comput Biol (2015) 0.75
Microtrabecular lattice of the cytoplasmic ground substance. Artifact or reality. J Cell Biol (1979) 4.61
Intracellular transport in neurons. Physiol Rev (1980) 3.83
Stereo high-voltage electron microscopy of whole cells of the human diploid line, WI-38. Am J Anat (1976) 3.06
Microtrabecular structure of the axoplasmic matrix: visualization of cross-linking structures and their distribution. J Cell Biol (1980) 2.81
Resolution in electron microscope radioautography. J Cell Biol (1969) 2.59
Mitochondria are associated with microtubules and not with intermediate filaments in cultured fibroblasts. Proc Natl Acad Sci U S A (1982) 2.23
Antibody decoration of neurofilaments. J Cell Biol (1981) 2.12
Axonal transport: each major rate component reflects the movement of distinct macromolecular complexes. Science (1981) 1.55
Axonal transport: components, mechanisms, and specificity. Annu Rev Neurosci (1979) 1.54
Nerve-specific enolase and creatine phosphokinase in axonal transport: soluble proteins and the axoplasmic matrix. Cell (1981) 1.35
Structural correlates of rapid axonal transport: evidence that microtubules may not be directly involved. Brain Res (1974) 1.29
The microstream concept of axoplasmic and dendritic transport. Adv Neurol (1975) 1.20
Axoplasmic transport of labeled proteins in rat ventral motoneurons. Exp Neurol (1968) 1.20
Reorganization of axoplasmic organelles following beta, beta'-iminodipropionitrile administration. J Cell Biol (1981) 1.19
Protein synthesis in synaptosomal fractions. Ultrastructural radioautographic study. J Cell Biol (1972) 1.01
Smooth endoplasmic reticulum and axonal transport. J Neurochem (1980) 0.98
Fast axonal transport in the presence of high Ca2+: evidence that microtubules are not required. Proc Natl Acad Sci U S A (1980) 0.96
Association of creatine phosphokinase with the cytoskeleton of cultured mammalian cells. J Cell Biol (1980) 0.90
High voltage electron microscopy studies of axoplasmic transport in neurons: a possible regulatory role for divalent cations. J Cell Biol (1982) 0.90
Axonal growth during regeneration: a quantitative autoradiographic study. J Cell Biol (1980) 0.85
Calcium and the mechanism of axoplasmic transport. Fed Proc (1982) 0.81
The role of fast transport in the nervous system. Neurosci Res Program Bull (1981) 0.79
Which organelles are necessary for fast neuronal transport? Neurosci Res Program Bull (1981) 0.78
Microtubules and the capacity of the system for rapid axonal transport. Fed Proc (1982) 0.78
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol (1999) 6.98
Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science (1996) 6.71
Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol (1996) 4.10
Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem (1995) 3.20
Nuclear lamins A and B1: different pathways of assembly during nuclear envelope formation in living cells. J Cell Biol (2000) 3.06
Paired helical filaments from Alzheimer disease patients contain cytoskeletal components. Proc Natl Acad Sci U S A (1985) 2.86
Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature (1997) 2.80
Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome. Nat Med (1996) 2.71
A high-density integrated genetic linkage and radiation hybrid map of the laboratory rat. Genome Res (1999) 2.49
Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A (2000) 2.46
Rapid movements of vimentin on microtubule tracks: kinesin-dependent assembly of intermediate filament networks. J Cell Biol (1998) 2.44
Immunohistochemical localization of glial fibrillary acidic protein in human glial neoplasms. Cancer (1980) 2.26
Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain (2001) 2.14
Responses to single quanta of light in retinal ganglion cells of the cat. Vision Res (1971) 2.09
The widespread alteration of neurites in Alzheimer's disease may be unrelated to amyloid deposition. Ann Neurol (1989) 2.07
Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases. Proc Natl Acad Sci U S A (1988) 2.04
A novel phenotype in familial Creutzfeldt-Jakob disease: prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease-resistant prion protein. Ann Neurol (1999) 1.98
Presenilin-1 mutations in Alzheimer's disease. Nature (2000) 1.97
pH-dependent stability and conformation of the recombinant human prion protein PrP(90-231). J Biol Chem (1997) 1.85
Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease. Proc Natl Acad Sci U S A (1998) 1.85
Membrane environment alters the conformational structure of the recombinant human prion protein. J Biol Chem (1999) 1.83
Typing prion isoforms. Nature (1997) 1.82
Prion protein expression in different species: analysis with a panel of new mAbs. Proc Natl Acad Sci U S A (1998) 1.80
Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations. Ann Neurol (1980) 1.78
Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med (1986) 1.73
Neurofibrillary changes in human brain. An immunocytochemical study with a neurofilament antiserum. J Neuropathol Exp Neurol (1983) 1.72
Functional implications for the microtubule-associated protein tau: localization in oligodendrocytes. Proc Natl Acad Sci U S A (1995) 1.67
Insights into the dynamic properties of keratin intermediate filaments in living epithelial cells. J Cell Biol (2001) 1.66
Absence of protease-resistant prion protein in the cerebrospinal fluid of Creutzfeldt-Jakob disease. J Pathol (2001) 1.61
Bodian's silver method stains neurofilament polypeptides. Science (1981) 1.59
Clinical features of fatal familial insomnia: phenotypic variability in relation to a polymorphism at codon 129 of the prion protein gene. Brain Pathol (1998) 1.56
Aggregation and fibrillization of the recombinant human prion protein huPrP90-231. Biochemistry (2000) 1.52
Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Neurology (2004) 1.49
Hyalinosis and Ym1/Ym2 gene expression in the stomach and respiratory tract of 129S4/SvJae and wild-type and CYP1A2-null B6, 129 mice. Am J Pathol (2001) 1.47
Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus. J Mol Biol (2000) 1.44
Familial mutations and the thermodynamic stability of the recombinant human prion protein. J Biol Chem (1998) 1.43
Review: the dynamics of the nuclear lamins during the cell cycle-- relationship between structure and function. J Struct Biol (2000) 1.42
Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea. Gut (1999) 1.42
Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease. Am J Pathol (1990) 1.41
Alteration of the serotonergic nervous system in fatal familial insomnia. Ann Neurol (2000) 1.41
Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol (1988) 1.40
Quality control of home monitoring of blood glucose concentrations. Br Med J (Clin Res Ed) (1984) 1.38
Myoclonic epilepsy with lafora bodies. Some ultrastructural, histochemical, and biochemical aspects. Arch Neurol (1971) 1.36
Reorganization of retinotectal projection following surgical operations on the optic tectum in goldfish. Exp Neurol (1971) 1.34
Amyloid precursor protein in senile plaques of Alzheimer disease. Lancet (1988) 1.33
Aberrant metal binding by prion protein in human prion disease. J Neurochem (2001) 1.33
Immunocytochemical properties of Alzheimer straight filaments. J Neurosci (1987) 1.32
Hirano body filaments contain actin and actin-associated proteins. J Neuropathol Exp Neurol (1987) 1.32
Nervous system in Pompe's disease. Ultrastructure and biochemistry. J Neuropathol Exp Neurol (1971) 1.31
Oxidative impairment in scrapie-infected mice is associated with brain metals perturbations and altered antioxidant activities. J Neurochem (2001) 1.30
Proteasomal degradation and N-terminal protease resistance of the codon 145 mutant prion protein. J Biol Chem (1999) 1.30
The chaperone protein BiP binds to a mutant prion protein and mediates its degradation by the proteasome. J Biol Chem (2000) 1.29
Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178. Neurology (1992) 1.29
Soluble amyloid beta-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid. Biochem Biophys Res Commun (1994) 1.27
Ultrastructural localization of beta-amyloid, tau, and ubiquitin epitopes in extracellular neurofibrillary tangles. Proc Natl Acad Sci U S A (1991) 1.26
Prion protein aggregation reverted by low temperature in transfected cells carrying a prion protein gene mutation. J Biol Chem (1997) 1.24
Allelic origin of the abnormal prion protein isoform in familial prion diseases. Nat Med (1997) 1.23
Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease. Proc Natl Acad Sci U S A (1998) 1.22
Neuronal and astrocytic differentiation in human neuroepithelial neoplasms. An immunohistochemical study. J Neuropathol Exp Neurol (1983) 1.21
Aluminum effect on slow axonal transport: a novel impairment of neurofilament transport. J Neurosci (1984) 1.21
Accessibility of a critical prion protein region involved in strain recognition and its implications for the early detection of prions. Cell Mol Life Sci (2008) 1.20
Puromycin: action on neuronal mitochondria. Science (1968) 1.20
Reorganization of axoplasmic organelles following beta, beta'-iminodipropionitrile administration. J Cell Biol (1981) 1.19
Glial fibrillary acidic protein (GFAP) in ependymal cells during development. An immunocytochemical study. Brain Res (1980) 1.19
A new type of late infantile amaurotic idiocy. The fine structure of the multilamellar cytosome. J Neuropathol Exp Neurol (1968) 1.18
Creutzfeldt-Jakob disease in unusually young patients who consumed venison. Arch Neurol (2001) 1.18
Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy. Ann Neurol (1988) 1.17
Effect of the D178N mutation and the codon 129 polymorphism on the metabolism of the prion protein. J Biol Chem (1996) 1.16
Reversibility of the reorganization of retinotectal projection in goldfish. Exp Neurol (1972) 1.16
Hirano bodies contain tau protein. Brain Res (1987) 1.14
Pathological reaction of astrocytes in perinatal brain injury. Immunohistochemical study. Acta Neuropathol (1986) 1.13
Influence of adaptation level on response pattern and sensitivity of ganglion cells in the cat's retina. J Physiol (1972) 1.13
Tau gene mutation in familial progressive subcortical gliosis. Nat Med (1999) 1.13
Human prion diseases. Curr Opin Neurol (1995) 1.13
Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes. Lab Invest (1988) 1.12
Function and evolution of neurofilament proteins. Ann N Y Acad Sci (1985) 1.12
Familial prion disease with a novel 144-bp insertion in the prion protein gene in a Basque family. Neurology (1997) 1.11
Heterogeneity of water-soluble amyloid beta-peptide in Alzheimer's disease and Down's syndrome brains. FEBS Lett (1997) 1.11
A subtype of sporadic prion disease mimicking fatal familial insomnia. Neurology (1999) 1.10
Neuropil threads of Alzheimer's disease show a marked alteration of the normal cytoskeleton. J Neurosci (1991) 1.10
Transthyretin amyloidosis: a new mutation associated with dementia. Ann Neurol (1997) 1.10
Cytoplasmic inclusions in juvenile amaurotic idiocy. J Pediatr (1969) 1.09
Microtubule-associated protein 2 within axons of spinal motor neurons: associations with microtubules and neurofilaments in normal and beta,beta'-iminodipropionitrile-treated axons. J Cell Biol (1985) 1.09
Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain. Am J Pathol (2000) 1.08